Oral Cancer: The Latest Advances in Clinical and Basic Research

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 156

Special Issue Editors


E-Mail Website
Guest Editor
Department of Oral and Maxillofacial Surgery, Institute of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
Interests: oral cancer; orthognathic surgery; cleft lip and palate; implantology; traumatology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Oral and Maxillofacial Surgery, Institute of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
Interests: signal transduction; oral diseases; oral surgery; cancer biology; apoptosis cell; culture phosphorylation; cell signaling; cell proliferation PCR

Special Issue Information

Dear Colleagues,

The number of patients with oral cancer has been growing in recent years. Generally speaking, diagnosis at a low stage is beneficial for a good prognosis, and recently, a new molecular target drug and immune checkpoint inhibitor were found to prolong survival after recurrence and distant metastasis. 

Although treatment results can be improved through chemoradiotherapy and surgery with wide resection and reconstruction, some patients suffer from poor prognosis.  We must always consider the appropriateness of new treatments and conduct basic research based on each patient's cancer prognosis.

In this Special Issue, we welcome original research articles and reviews on the latest advances in clinical and basic research related to oral cancer.

We look forward to receiving your contributions.

Dr. Kenji Yamagata
Dr. Fumihiko Uchida
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oral cancer
  • clinical research
  • basic research
  • surgery
  • radiotherapy
  • chemotherapy
  • molecular biology
  • immune checkpoint inhibitor

Published Papers

This special issue is now open for submission.
Back to TopTop